Analytical Verification HPLC peptide analysis and LC-MS verification support peptide identity confirmation, purity evaluation, analytical consistency, and qualified laboratory research workflows
After sixteen weeks, dogs receiving the medication lost an average of 18% of their body weight
population, with the share of GLP-1 RA fills for non-diabetes-related conditions nearly doubling from 7.4 percent in 2019 to 14.3 percent in 2022
GLS1 is the main isoform expressed in cancer cells and has been shown to be upregulated in a wide variety of cancers, including breast, lung, cervix and brain [36]
Thus, developing an oral GLP-1 medication could significantly increase adoption among women over the age of 35, likely the largest GLP-1 patient group